Revised Schedule M: where sites actually fail

Most manufacturers approached the revised Schedule M as a capital problem. Air handling, finishes, differential pressures, a new QC block. Those are real costs and they get board attention because they arrive as a quotation.

The gaps that actually hold sites up at inspection are cheaper to fix and much easier to miss.

The pattern

Across gap assessments, the recurring shortfalls cluster in four places, none of which is primarily a construction item.

1. The Pharmaceutical Quality System exists on paper only

The schedule expects a quality system that demonstrably drives decisions. Many sites have every required SOP and no evidence that the system produced an outcome. Management review minutes that record attendance but no decision. Quality risk assessments filed at the point of approval and never revisited when the process changed.

An inspector does not audit your SOP index. They pick a decision your site made and trace whether the system governed it.

2. Product quality review that reviews nothing

The APQR is the clearest tell. A compliant-looking document that tabulates a year of batch data, states that all results were within specification, and concludes that no action is required — while the trend inside the table drifts steadily towards one limit.

The review is meant to detect the drift and trigger something. If your last three annual reviews concluded “no action required” for every product, that is worth examining before someone else examines it.

3. Data integrity applied only to the obvious systems

Sites harden the HPLC software and leave the balance printouts, the temperature chart recorders, the manual logbooks and the spreadsheet doing a stability calculation entirely unaddressed. ALCOA+ applies to the record, not to the sophistication of the instrument that produced it.

The spreadsheet is the most commonly missed. If a calculation that supports a release decision lives in an unvalidated, unlocked workbook on a shared drive, that is a finding.

4. Training recorded but not effective

Attendance sheets are not evidence of competence. The schedule’s expectation — and every modern GMP code’s expectation — is that training effectiveness is assessed. When an operator cannot explain why an intervention is recorded, the training record showing they attended the session becomes evidence against you rather than for you.

What a workable transition looks like

The sequence that works is not the sequence that feels natural.

1. Assess against the clause, not against your memory of the old schedule. A structured clause-by-clause walkthrough takes days, not weeks, and it prevents the far more expensive mistake of remediating the wrong thing.
2. Score every gap on patient risk and on inspection exposure. These are different axes and both matter. A low-risk gap that an inspector will certainly find still costs you.
3. Do the system work in parallel with the capital work. Civil work has a lead time you cannot compress. Quality system work does not — and it is what the inspector will spend most of their time on.
4. Build the evidence file as you go. The transition needs to be presentable as a narrative: what we found, how we ranked it, what we did, how we know it worked. Assembling that retrospectively is far harder than maintaining it.

The honest position

Some sites will not close every gap by their target date. That is survivable. What is not survivable is being unable to show that you knew where you stood, ranked the gaps sensibly, and made demonstrable progress against a plan.

An inspector will forgive an open item with a credible closure date. They are much less forgiving of a site that did not know the item was open.